z-logo
open-access-imgOpen Access
P66 Adalimumab originator versus biosimilar in children and young people with JIA
Author(s) -
Lianne KearsleyFleet,
Sarthak Jain,
Eileen Baildam,
Michael W. Beresford,
Sharon Douglas,
Helen Foster,
T. R. E. Southwood,
Kimme L Hyrich
Publication year - 2022
Publication title -
rheumatology advances in practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.539
H-Index - 4
ISSN - 2514-1775
DOI - 10.1093/rap/rkac067.066
Subject(s) - medicine , adalimumab , biosimilar , demographics , etanercept , physical therapy , disease , pediatrics , rheumatoid arthritis , demography , sociology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom